Terveystalo PLC (OTCPK:TTALF)
$ 8.95 -4 (-30.89%) Market Cap: 1.14 Bil Enterprise Value: 1.79 Bil PE Ratio: 14.31 PB Ratio: 1.84 GF Score: 69/100

Q4 2025 Terveystalo Oyj Earnings Call Transcript

Feb 13, 2026 / 08:30AM GMT
Release Date Price: $12.95

Key Points

Positve
  • Terveystalo PLC (FRA:4TS) achieved all-time high profitability across all segments, demonstrating strong financial performance despite challenging market conditions.
  • The company has successfully improved operating leverage and efficiency, leading to robust results even during market headwinds.
  • Terveystalo PLC (FRA:4TS) is investing €20 million in a two-year program to renew products and services, particularly in occupational healthcare, which is expected to drive future growth.
  • The acquisition of Hochda in dental services is a significant milestone, aligning with the company's strategy to double the business and profitability in this segment.
  • The company continues to lead in digital transformation, launching new platforms like ELA for professionals and AI-assisted appointment systems, enhancing efficiency and customer experience.
Negative
  • Terveystalo PLC (FRA:4TS) faces revenue headwinds due to the post-cyclical nature of the healthcare industry and macroeconomic challenges.
  • The frequency of use of services has declined across all segments, impacting revenue despite maintaining the same number of customers as the previous year.
  • The company anticipates a challenging first half of 2026, with profitability expected to be lower than the previous year due to weak market conditions and a mild flu season.
  • There is uncertainty in the public sector market, with unpredictable demand and cautious behavior from wellbeing counties, affecting potential growth opportunities.
  • The company has incurred significant one-off costs related to restructuring and consulting fees, particularly in Sweden, which have impacted reported earnings.
Operator

Good morning everybody and welcome to Tervasos Q4 and full year 2025 results call and webcast. As usual, we will go through the results with our CEO Will Leijo and our CFO Yuso Payunan, and we will follow that with a Q&A. My name is Kathy Coxen and I am responsible for investor relations and sustainability here at Tervastalo.

We'll take the questions via the phone lines first, and then follow with the questions via the webcast at the end of the presentation. Without further ado over the.

Ville Iho
Terveystalo Oyj - President, Chief Executive Officer, Member of the Management Group

UV. Thanks and good morning from.

Cold and beautiful Helsinki.

Let's dive into it, Tervestalo, results, 2025.

It's again, time to, take a couple of steps back and look at how we performed, last year. Sort of the big headline here is profitability and efficiency. If one looks at our performance, financial performance, we are delivering all-time high profitability, and as you can see later, across all of the segments, they are improving.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot